About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT01671540

Effects of IPV Assessed With Functional Imaging

In this study the invetigators seek an answer on the following hypothesis: * What are the long term effects of an IPV treatment evaluated with classical outcome parameters? (FEV1, Raw) * Is the possi...

Lead sponsor: University Hospital, Antwerp•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Kris Ides, Msc

CONTACT

036418267 kris.ides@artesis.be

Sponsors

Lead Sponsor

University Hospital, Antwerp

Collaborators

Artesis University College, Antwerp
FLUIDDA nv

A Multicenter study conducted in university Hospital Antwerp (UZA) and ZNA Middelheim. Tests are taken before and after one week IPV treatment. IPV is applied for 1 week during the physical therapy treatment of chronic obstructive pulmonary desease (COPD) patients admitted to the hospital for an excarebation. The IPV treatment is an additional treatment upon the standard treatment of the patients. The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises. Patients are randomized into either the experimental group or the control group. The control group receives a standard physical therapy treatment without additional IPV treatment.

Age

30 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients admitted in the hospital for a acute exacerbation
•Mild to severe COPD

Exclusion Criteria

•Ischemic / ventricular aritmic
•Tracheotomise
•Pneumothorax
•Facial deformity
•Recent nose, mouth or ear operations
•Recent gastric operations.
•Intubated
•Epilepsy

Related studies

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

NCT07190209 · Chronic Obstructive Pulmonary Disease

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

Study of Patient With Frequent Exacerbations in Moscow

NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)

RECRUITINGPhase 4

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

NCT07073950 · Chronic Obstructive Pulmonary Disease, Hyperinflation

Acute Effect of Different Frequency of Whole Body Vibration (WBV) on Healthy and Chronic Obstructive Pulmonary Disease (COPD)

NCT07509606 · Chronic Obstructive Pulmonary Disease (COPD), Whole Body Vibration

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 28, 2015Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment20

Start dateSep 2011

Last updatedMay 28, 2015

Condition

Chronic Obstructive Pulmonary Disease

Locations shown

University Hospital Antwerp

Edegem, Antwerp

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 28, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions